NPI: 1962470468 · ORLANDO, FL 32825 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/09/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/09/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,794 | $1.75M |
| 2019 | 15,154 | $2.33M |
| 2020 | 22,647 | $3.02M |
| 2021 | 12,442 | $354K |
| 2022 | 5,717 | $538K |
| 2023 | 1,778 | $57K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 23,768 | 1,137 | $2.66M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 20,776 | 1,424 | $2.43M |
| J1270 | Injection, doxercalciferol, 1 mcg | 13,064 | 844 | $1.51M |
| A4657 | Syringe, with or without needle, each | 2,955 | 1,143 | $553K |
| 82728 | 1,053 | 695 | $152K | |
| 83550 | 1,026 | 673 | $146K | |
| 83540 | 1,023 | 672 | $145K | |
| 85048 | 936 | 596 | $138K | |
| 85041 | 974 | 623 | $138K | |
| 83970 | 684 | 430 | $81K | |
| J1756 | Injection, iron sucrose, 1 mg | 973 | 131 | $68K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 117 | 54 | $10K |
| 82108 | 72 | 54 | $8K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 32 | 25 | $7K |
| 82607 | 79 | 44 | $5K |